SanBio Company Limited provided revised consolidated earnings guidance for the year ending January 31, 2019. For the year, the company now expects operating revenue of JPY 742 million compared to previous forecast of JPY 1,025 million, operating loss of JPY 3,881 million compared to previous forecast of JPY 3,540 million, ordinary loss of JPY 2,972 million compared to previous forecast of JPY 2,529 million, net loss attributable to owners of parent was JPY 2,978 million or JPY 59.88 per share compared to previous forecast of JPY 2,564 million or JPY 56.00 per share.